APA (7th ed.) Citation

Murayama, N., Inomata, M., Furukawa, D., Hashizume, M., Takata, N., Seto, Z., . . . Hirabayashi, K. (2026). TTF-1 expression is associated with survival in patients with non-squamous non-small cell lung cancer treated with immune checkpoint inhibitor therapy. Molecular & Clinical Oncology, 24(2), N.PAG. https://doi.org/10.3892/mco.2025.2920

Chicago Style (17th ed.) Citation

Murayama, Nozomu, et al. "TTF-1 Expression Is Associated with Survival in Patients with Non-squamous Non-small Cell Lung Cancer Treated with Immune Checkpoint Inhibitor Therapy." Molecular & Clinical Oncology 24, no. 2 (2026): N.PAG. https://doi.org/10.3892/mco.2025.2920.

MLA (9th ed.) Citation

Murayama, Nozomu, et al. "TTF-1 Expression Is Associated with Survival in Patients with Non-squamous Non-small Cell Lung Cancer Treated with Immune Checkpoint Inhibitor Therapy." Molecular & Clinical Oncology, vol. 24, no. 2, 2026, p. N.PAG, https://doi.org/10.3892/mco.2025.2920.